Linezolid — Drug Intelligence | 35 EU Trials

Filter these 35 trials by condition, phase, country and more.

Open in Search →

35 Registered trials

21 Recruiting

7 Completed trials

23 Sponsors

22 Countries

Phase III

Phase II

Phase IV

Phase III: 12 Phase II: 5 Phase III/IV: 1 Phase IV: 15 Phase I: 1 Phase I (Other): 1

Oversight events:

2 temporary halts across 2 trials

View oversight register →

Indications tested

Sepsis 4 Bacterial infection 3 Mycobacterium abscessus infection 1 Abdominal infection 1 Diabetic foot infection 1 Infection 1 Brain abscess 1 Urinary tract infection 1 Implant site infection 1 Antibiotic level therapeutic 1 Endocarditis enterococcal 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 6 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 4 Rigshospitalet 3 Medical University Of Vienna 2 Universitair Ziekenhuis Gent 2 Aalborg University Hospital 1 Centre Hospitalier Universitaire Amiens Picardie 1 Centre Hospitalier Universitaire De Nantes 1 Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca 1 Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau 1 Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia 1 Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela 1

All trials — page 2

35 total

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) Recruiting

2024-512759-19-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting

2023-506575-99-00 Phase II 1 country The University Of Queensland
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Phase IV 4 countries Aalborg University Hospital
Pharmacokinetics of antibiotics in cerebrospinal fluid of children with malignant brain tumors – a pilot study Recruiting

2024-518808-43-00 Phase I 1 country Medical University Of Vienna
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended

2023-509075-17-00 Phase II 1 country Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca
Oral Alternative Antibiotics for Patients with Syphilis Ended

2024-514984-24-00 Phase III/IV 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
Pharmacokinetics of antibiotics in cerebrospinal fluid of children with external ventricular drain Ended

2024-515791-12-00 Phase I (Other) 1 country Medical University Of Vienna
SePkLin Study: Pragmatic, Multicenter, Randomized, Controlled Clinical Trial in Patients with Sepsis to Evaluate the Safety and Efficacy of … Ended

2024-513890-30-00 Phase IV 1 country Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela

Showing 25–35 of 35 trials

← All drugs A–Z